Département de Biologie Moléculaire, Biochimie Médicale et Pathologie, Centre de Recherche en Cancérologie, Centre de Recherche du CHU de Québec, Faculté de Médecine, Université Laval, Québec, Parti Québécois, Canada.
Département de Psychiatrie et de Neurosciences, Centre de Recherche, Institut Universitaire en Santé mentale de Québec, Faculté de Médecine, Université Laval, Québec, Parti Québécois, Canada.
PLoS One. 2020 May 4;15(5):e0231894. doi: 10.1371/journal.pone.0231894. eCollection 2020.
Stress granules (SG) are cytoplasmic RNA granules that form during various types of stress known to inhibit general translation, including oxidative stress, hypoxia, endoplasmic reticulum stress (ER), ionizing radiations or viral infection. Induction of these SG promotes cell survival in part through sequestration of proapoptotic molecules, resulting in the inactivation of cell death pathways. SG also form in cancer cells, but studies investigating their formation upon treatment with chemotherapeutics are very limited. Here we identified Lapatinib (Tykerb / Tyverb®), a tyrosine kinase inhibitor used for the treatment of breast cancers as a new inducer of SG in breast cancer cells. Lapatinib-induced SG formation correlates with the inhibition of general translation initiation which involves the phosphorylation of the translation initiation factor eIF2α through the kinase PERK. Disrupting PERK-SG formation by PERK depletion experiments sensitizes resistant breast cancer cells to Lapatinib. This study further supports the assumption that treatment with anticancer drugs activates the SG pathway, which may constitute an intrinsic stress response used by cancer cells to resist treatment.
应激颗粒(SG)是细胞质 RNA 颗粒,在已知抑制一般翻译的各种应激条件下形成,包括氧化应激、缺氧、内质网应激(ER)、电离辐射或病毒感染。这些 SG 的诱导促进细胞存活,部分原因是通过隔离促凋亡分子,从而使细胞死亡途径失活。SG 也在癌细胞中形成,但研究调查它们在化疗药物治疗下的形成非常有限。在这里,我们确定 Lapatinib(Tykerb/Tyverb®),一种用于治疗乳腺癌的酪氨酸激酶抑制剂,是乳腺癌细胞中 SG 的新诱导剂。Lapatinib 诱导的 SG 形成与一般翻译起始的抑制相关,这涉及通过激酶 PERK 使翻译起始因子 eIF2α 磷酸化。通过 PERK 耗竭实验破坏 PERK-SG 的形成,使耐药乳腺癌细胞对 Lapatinib 敏感。这项研究进一步支持了这样的假设,即抗癌药物的治疗激活了 SG 途径,这可能构成癌细胞抵抗治疗的内在应激反应。